Autoantibody targeting therapies in post COVID syndrome and myalgic encephalomyelitis/chronic fatigue syndrome
About
Article information:
Expert Opin Biol Ther. 2025 Apr 10.
Interventions:
Rovunaptabin (BC007)
Immunoadsorption
Plasmapheresis
Rituximab (L01FA01)
Apparative Therapy
Immunoglobulins (J06B)
Daratumumab (L01FC01)
Efgartigimod (L04AA58)
Immunoadsorption
Plasmapheresis
Rituximab (L01FA01)
Apparative Therapy
Immunoglobulins (J06B)
Daratumumab (L01FC01)
Efgartigimod (L04AA58)
Link
DOI
Abstract
No abstract available.
Authors (all)
Felix Wohlrab, Mailam Eltity, Friederike Ufer, Friedemann Paul, Carmen Scheibenbogen, Judith Bellmann-Strobl
Linked author profiles see list below.
Research projects
0
Research areas
3
Research types
1
Research networks
0
People
3
Research projects
This publication has no research projects linked or they are not public yet.
Contact
ME/CFS Research Foundation
Ballindamm 27, 20095 Hamburg, Germany
Copyright © 2022 ME/CFS Research Foundation
Imprint -
Data privacy statement